Research & Development System

The mission of Staanmed Research Centre is to develop ground-breaking medicines and works towards novel drug delivery systems, new molecule research, and API development. It is driven by development expertise and operational excellence to create innovative and effective treatment for the betterment of society. Today, the success of Staanmed Research Centre is attributed to the capabilities of its highly skilled employees and the work environment. Staanmed Research Centre promotes teamwork in order to produce the best medicines and is committed to building a healthier and happier world.


Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally administered drugs, this usually involves incorporating the drug into a tablet or a capsule. It is important to make the distinction that a tablet contains a variety of other potentially inert substances apart from the drug itself, and studies have to be carried out to ensure that the encapsulated drug is compatible with these other substances in a way that does not cause harm, whether direct or indirect.

Preformulation involves the characterization of a drug's physical, chemical, and mechanical properties in order to choose what other ingredients (excipients) should be used in the preparation. In dealing with protein pre-formulation, the important aspect is to understand the solution behavior of a given protein under a variety of stress conditions such as freeze/thaw, temperature, shear stress among others to identify mechanisms of degradation and therefore its mitigation.


The Staanmede Pharma have well-planned and state-of-the-art facilities at Micro Labs have led to its accelerated growth in the pharmaceutical sector. Infrastructure plays a key role in the development and progress of a company.The reputation of our company is built on Manufacturing and R&D facilities that are designed to meet global standards, and stringent Quality standards that ensure we deliver only the best formulations and products.

The manufacturing units are designed to meet the current global standards of GMP and safety standards for personnel


Team at Staanmed works collectively that ensure investment in biopharmaceutical innovation.

The leadership of Staanmed Pharma includes senior leaders representing the world’s top developers of new treatments and cures who are committed to improving health care through innovation and research. The senior executive team at Staanmed Pharma works closely with the board of directors to advance policies that ensure continued investment in biopharmaceutical innovation.

Global Presence

We are in constant search of partners that match our values, work ethics and commitment to patients. We regard partnership and collaboration as an integral part of our business strategy. This important initiative is supported by a dedicated team for global business development, licensing and post-alliance management.

Our track-record of successful collaborations includes in/out licensing of products and technologies, joint ventures, as well as mergers & acquisitions. We offer a full range of both global and local integrated, organisational and commercial capabilities, combined with a track record of successful product launches. The financial strength of our company ensures appropriate investments in products.